Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · IEX Real-Time Price · USD

48.48

+1.53 (3.26%)

At close: Jul 26, 2024, 4:00 PM

47.80

-0.68 (-1.40%)

After-hours: Jul 26, 2024, 5:48 PM EDT

Soleno Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Selling, General & Admin	19.1	13.48	9.84	10.81	8.76	6.93	Upgrade
Research & Development	34.48	25.19	15.27	21.45	23.19	16.27	Upgrade
Operating Expenses	53.57	38.67	25.11	32.26	31.95	23.2	Upgrade
Operating Income	-53.57	-38.67	-25.11	-32.26	-31.95	-23.2	Upgrade
Interest & Investment Income	4.54	2.58	0.3	0.11	0.01	0.15	Upgrade
Earnings From Equity Investments	-	-	-	-	-	-0.48	Upgrade
Other Non Operating Income (Expenses)	-0.18	-0.18	0.03	0.51	11.64	-6.96	Upgrade
EBT Excluding Unusual Items	-49.21	-36.27	-24.78	-31.64	-20.3	-30.49	Upgrade
Other Unusual Items	-2.82	-2.71	0.71	0.73	-4.34	-0.29	Upgrade
Pretax Income	-52.03	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade
Earnings From Continuing Operations	-52.03	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade
Net Income	-52.03	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade
Net Income to Common	-52.03	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade
Shares Outstanding (Basic)	23	16	8	5	4	2	Upgrade
Shares Outstanding (Diluted)	23	16	8	5	4	2	Upgrade
Shares Change (YoY)	145.96%	96.40%	57.90%	27.39%	83.41%	62.77%	Upgrade
EPS (Basic)	-2.24	-2.36	-2.87	-5.81	-5.90	-13.52	Upgrade
EPS (Diluted)	-2.24	-2.36	-2.87	-5.81	-5.90	-13.52	Upgrade
Free Cash Flow	-30.75	-24.94	-20.79	-27.79	-25.23	-17.4	Upgrade
Free Cash Flow Per Share	-1.33	-1.51	-2.48	-5.23	-6.04	-7.64	Upgrade
EBITDA	-51.62	-36.71	-23.15	-30.3	-30	-21.24	Upgrade
D&A For EBITDA	1.96	1.96	1.96	1.96	1.95	1.96	Upgrade
EBIT	-53.57	-38.67	-25.11	-32.26	-31.95	-23.2	Upgrade

Source: S&P Capital IQ. Standard template.